Treatments for fibrosis development and progression: Lessons learned from preclinical models and potential impact on human conditions such as scleroderma, pulmonary fibrosis, hypertrophic scarring and tendinopathies

ISSN Print: 1937-6871
ISSN Online: 1937-688X
www.scirp.org/journal/jbise
E-mail: jbise@scirp.org

has been cited by the following article(s):

[1]	Neuronal pathways in tendon healing and tendinopathy: update
	2016

[2]	A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps …
	Journal of Biomechanics, 2015

[3]	MS: IJI 452095-Revised Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should mast cells be targeted?
	International Journal of Inflammation, 2015

[4]	A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles
	Journal of biomechanics, 2015

[5]	Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
	International Journal of Inflammation, 2015

[6]	Neuronal pathways in tendon healing and tendinopathy–update
	Front Biosci (Landmark Ed), 2014

[1]	Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted? International Journal of Inflammation, 2015 DOI:10.1155/2015/452095

[2]	A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles Journal of Biomechanics, 2015 DOI:10.1016/j.jbiomech.2015.05.018

[3]	A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles Journal of Biomechanics, 2015 DOI:10.1016/j.jbiomech.2015.05.018